Geneos Wealth Management’s Medpace MEDP Stock Holding History

Geneos Wealth Management’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$530	Buy	+1	New	+$462	﹤0.01%	2472
2026 Q1	–	Sell	-1	Closed	-$562	–	2533
2025 Q4	$562	Sell	1 -24	-96%	-$13.6K	﹤0.01%	2454
2025 Q3	$12.9K	Sell	25 -67	-73%	-$29.3K	﹤0.01%	1879
2025 Q2	$28.9K	Sell	92 -2	-2%	-$600	﹤0.01%	1851
2025 Q1	$28.6K	Buy	94 +37	+65%	+$12.4K	﹤0.01%	1759
2024 Q4	$18.9K	Sell	57 -10	-15%	-$3.39K	﹤0.01%	1752
2024 Q3	$22.4K	Buy	+67	New	+$25.5K	﹤0.01%	1525
2021 Q2	–	Sell	-13	Closed	-$2K	–	3009
2021 Q1	$2K	Buy	+13	New	+$1.99K	﹤0.01%	2905

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geneos Wealth Management's MEDP Position: Q2 2026 in Review

Geneos Wealth Management opened a new position in Medpace (MEDP) in Q2 2026: 1 share worth $530. The stake represents ﹤0.01% of the portfolio and ranks #2472 among its holdings. This is a return to the name: Geneos Wealth Management previously reported a position in MEDP as recently as Q4 2025.

Geneos Wealth Management first reported a position in MEDP in Q1 2021 and has held it in 8 quarters since. The position peaked at $28.9K in Q2 2025. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

Geneos Wealth Management held 1 share of Medpace worth $530 as of Q2 2026.
Medpace was a new Geneos Wealth Management position in Q2 2026.
Medpace made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #2472 holding.
Geneos Wealth Management first reported a position in Medpace in Q1 2021 and has held it in 8 quarters since.
Geneos Wealth Management's Medpace position peaked at $28.9K in Q2 2025.
694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.